The multifaceted modulations by dapagliflozin in preventing hyperglycemia-induced diabetic nephropathy through glucose transporters and PPARα.

OBJECTIVES

Diabetic nephropathy (DN) contributes to the higher mortality, and Forxiga (dapagliflozin) effectively improves clinical outcomes of patients with type 2 diabetes. However, the effects of dapagliflozin on hyperglycemia-induced DN remain unclear.

METHODS

Streptozotocin (STZ)-induced diabetic rats were used to investigate hyperglycemia-induced DN, and various parameters were evaluated for the oral administration of dapagliflozin (1.2 mg/kg/day) for 12 weeks in STZ-induced diabetic rats, including serum metabolic parameters, kidney morphology, renal glycogen, and renal collagen. Additionally, the biomedical mechanisms were further assessed by western blotting and immunohistochemistry staining.

RESULTS

Compared to normal rats, we observed significant changes in STZ-induced diabetic rats for metabolic parameters, renal pathogenesis, glycogen deposition, and collagen accumulation. However, the treatment with dapagliflozin for 12 weeks in STZ-induced diabetic rats significantly increased body weight, decreased plasma glucose, triglyceride, cholesterol, creatinine and blood urea nitrogen levels, and improved renal pathology, glycogen deposition, and collagen accumulation compared with STZ-induced diabetic rats. Additionally, hyperglycemia-induced DN further elevated renal expressions of N-cadherin, yes-associated protein (YAP), fibronectin, Myosin IIB, alpha-smooth muscle actin (α-SMA), CD11b, tumor necrosis factor alpha (TNF-α), caspase-3, acetyl superoxide dismutase 2 (AcSOD2) involved in renal epithelial-to-mesenchymal transition (EMT), fibrosis, inflammation, apoptosis, and oxidative stress, which were attenuated by dapagliflozin. Moreover, the higher expressions of renal glucose transporter 2 (GLUT2) and GLUT4, and lower expressions of renal peroxisome proliferator-activated receptor α (PPARα) in STZ-induced diabetic rats were reversed by dapagliflozin.

CONCLUSIONS

Dapagliflozin in STZ-induced diabetic rats exhibited anti-inflammation, anti-oxidation, EMT modulation, anti-apoptosis, and anti-fibrosis through the mediation of renal GLUT2, GLUT4, and PPARα expressions in the prevention of hyperglycemia-induced DN.